Michael J. Crowley

Michael J. Crowley is a Senior Scientist in In Vivo Hematology Oncology at AstraZeneca, where they are currently involved in significant scientific advances aimed at improving disease diagnosis and treatment. They have previously held positions as Scientist at eGenesis, Inc. and Scientist II at SalioGen Therapeutics. Michael received a Ph.D. in Physiology, Biophysics and Systems Biology from Weill Cornell Graduate School of Medical Sciences after earning an MS in Biology from New York University and a B.S. in Biology from Dickinson College. Their research experience includes various techniques such as cell culture, PCR, and next-generation sequencing, alongside an internship at Malaria Consortium focused on neglected tropical diseases.